...
首页> 外文期刊>Histopathology: Official Journal of the British Division of the International Academy of Pathology >Epstein-Barr virus-associated large B-cell lymphoma transformation in marginal zone B-cell lymphoma: a series of four cases
【24h】

Epstein-Barr virus-associated large B-cell lymphoma transformation in marginal zone B-cell lymphoma: a series of four cases

机译:Epstein-BARR病毒相关的大B细胞淋巴瘤在边缘区B细胞淋巴瘤中:一系列四种情况

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aims To present four examples of clonally related Epstein-Barr virus (EBV)-associated large-cell transformation of marginal zone lymphoma (MZL) (of nodal, extranodal and splenic types), occurring 120, 11 and 5 months after the initial diagnosis in three instances, and concurrently in one case; and to discuss several interesting features of EBV infection. Methods and results Somatic mutations were detected by use of a customised panel for next-generation sequencing and polymerase chain reaction studies ofIgHin both low-grade and high-grade components of each case. In case 1, the initial biopsy of nodal MZL showed scattered EBV-positive cells, which might constitute an indication of EBV-induced progression. Case 2 showed heterogeneous EBV expression, a phenomenon attributable to loss of the EBV episomes during cell division, or to a secondary superinfection or reactivation of the virus. In case 3, p53 overexpression related to gene mutation and EBV-encoded small RNAs were identified in the same neoplastic component. In case 4, the mucosa-associated lymphoid tissue-type MZL and the high-grade component were identified concurrently in a patient previously treated with methotrexate for an autoimmune disorder. Conclusion These data suggest that the presence of EBV should be added to the list of potential markers to be analysed for MZL prognosis.
机译:旨在呈现克隆相关的Epstein-BART病毒(EBV)的四个例子 - 分配的边缘区淋巴瘤(MZL)(NODAL,外侧和脾型)的大细胞转化,发生在初步诊断后的120,11和5个月内三个实例,并在一个案例中同时;并讨论EBV感染的几个有趣特征。方法和结果通过使用用于每种情况的低级和高级部件的下一代测序和聚合酶链反应研究的定制组检测体细胞突变。在情况1中,节点MZL的初始活检显示散射的EBV阳性细胞,其可能构成EBV诱导的进展的指示。案例2显示出非均相EBV表达,其归因于细胞分裂期间eBV血泡的现象,或对病毒的二次超级染色或再活化。在同一肿瘤组分中鉴定出与基因突变和EBV编码的小RNA相关的P53过表达。在壳体4中,在先前用甲氨蝶呤治疗的患者中同时鉴定粘膜相关淋巴组织型MZL和高级组分,用于对甲氨蝶呤进行自身免疫疾病。结论这些数据表明,应将EBV的存在添加到潜在标志物列表中,以分析MZL预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号